1619 related articles for article (PubMed ID: 31188543)
1. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway.
Sun Q; Li J; Li F; Li H; Bei S; Zhang X; Feng L
Cell Prolif; 2019 Nov; 52(6):e12687. PubMed ID: 31468594
[TBL] [Abstract][Full Text] [Related]
4. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
Ma X; Ren H; Zhang Y; Wang B; Ma H
Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
[TBL] [Abstract][Full Text] [Related]
5. Targeted-regulating of miR-515-5p by LncRNA LOXL1-AS1 on the proliferation and migration of trophoblast cells.
Zhang L; Wan Q; Zhou H
Exp Mol Pathol; 2021 Feb; 118():104588. PubMed ID: 33278425
[TBL] [Abstract][Full Text] [Related]
6. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
Guo T; Peng S; Liu D; Li Y
Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
Yang X; Xing G; Liu S; Li B; He Y; Wang F
Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
Luo JF; Xu J; Zheng JZ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
14. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
Wu C; Zhang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis.
Leng W; Liu Q; Zhang S; Sun D; Guo Y
Cancer Biol Ther; 2020 Nov; 21(11):1072-1080. PubMed ID: 33138677
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
Ma Y; Bu D; Long J; Chai W; Dong J
J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
[TBL] [Abstract][Full Text] [Related]
18. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis.
Yi B; Li H; Cai H; Lou X; Yu M; Li Z
J Cell Mol Med; 2022 Jan; 26(2):475-490. PubMed ID: 34890108
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Zhang G; He X; Ren C; Lin J; Wang Q
J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
